Targeting ATG4 in cancer therapy

Yuanyuan Fu, Zhiying Huang, Liang Hong, Jia Hong Lu, Du Feng, Xiao-Ming Yin, Min Li

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Autophagy is a lysosome-mediated degradation pathway that enables the degradation and recycling of cytoplasmic components to sustain metabolic homoeostasis. Recently, autophagy has been reported to have an astonishing number of connections to cancer, as tumor cells require proficient autophagy in response to metabolic and therapeutic stresses to sustain cell proliferation. Autophagy-related gene 4 (ATG4) is essential for autophagy by affecting autophagosome formation through processing full-length microtubule-associated protein 1A/1B-light chain 3 (pro-LC3) and lipidated LC3. An increasing amount of evidence suggests that ATG4B expression is elevated in certain types of cancer, implying that ATG4B is a potential anticancer target. In this review, we address the central roles of ATG4B in the autophagy machinery and in targeted cancer therapy. Specifically, we discuss how pharmacologically inhibiting ATG4B can benefit cancer therapies.

Original languageEnglish (US)
Article number649
JournalCancers
Volume11
Issue number5
DOIs
StatePublished - May 1 2019
Externally publishedYes

Fingerprint

Autophagy
Genes
Neoplasms
Therapeutics
Recycling
Lysosomes
Homeostasis
Cell Proliferation
Light

Keywords

  • ATG4
  • ATG4B
  • Autophagy
  • Cancer therapy

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Fu, Y., Huang, Z., Hong, L., Lu, J. H., Feng, D., Yin, X-M., & Li, M. (2019). Targeting ATG4 in cancer therapy. Cancers, 11(5), [649]. https://doi.org/10.3390/cancers11050649

Targeting ATG4 in cancer therapy. / Fu, Yuanyuan; Huang, Zhiying; Hong, Liang; Lu, Jia Hong; Feng, Du; Yin, Xiao-Ming; Li, Min.

In: Cancers, Vol. 11, No. 5, 649, 01.05.2019.

Research output: Contribution to journalArticle

Fu, Y, Huang, Z, Hong, L, Lu, JH, Feng, D, Yin, X-M & Li, M 2019, 'Targeting ATG4 in cancer therapy', Cancers, vol. 11, no. 5, 649. https://doi.org/10.3390/cancers11050649
Fu Y, Huang Z, Hong L, Lu JH, Feng D, Yin X-M et al. Targeting ATG4 in cancer therapy. Cancers. 2019 May 1;11(5). 649. https://doi.org/10.3390/cancers11050649
Fu, Yuanyuan ; Huang, Zhiying ; Hong, Liang ; Lu, Jia Hong ; Feng, Du ; Yin, Xiao-Ming ; Li, Min. / Targeting ATG4 in cancer therapy. In: Cancers. 2019 ; Vol. 11, No. 5.
@article{24914294d41941e8896269382b6cfb95,
title = "Targeting ATG4 in cancer therapy",
abstract = "Autophagy is a lysosome-mediated degradation pathway that enables the degradation and recycling of cytoplasmic components to sustain metabolic homoeostasis. Recently, autophagy has been reported to have an astonishing number of connections to cancer, as tumor cells require proficient autophagy in response to metabolic and therapeutic stresses to sustain cell proliferation. Autophagy-related gene 4 (ATG4) is essential for autophagy by affecting autophagosome formation through processing full-length microtubule-associated protein 1A/1B-light chain 3 (pro-LC3) and lipidated LC3. An increasing amount of evidence suggests that ATG4B expression is elevated in certain types of cancer, implying that ATG4B is a potential anticancer target. In this review, we address the central roles of ATG4B in the autophagy machinery and in targeted cancer therapy. Specifically, we discuss how pharmacologically inhibiting ATG4B can benefit cancer therapies.",
keywords = "ATG4, ATG4B, Autophagy, Cancer therapy",
author = "Yuanyuan Fu and Zhiying Huang and Liang Hong and Lu, {Jia Hong} and Du Feng and Xiao-Ming Yin and Min Li",
year = "2019",
month = "5",
day = "1",
doi = "10.3390/cancers11050649",
language = "English (US)",
volume = "11",
journal = "Cancers",
issn = "2072-6694",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "5",

}

TY - JOUR

T1 - Targeting ATG4 in cancer therapy

AU - Fu, Yuanyuan

AU - Huang, Zhiying

AU - Hong, Liang

AU - Lu, Jia Hong

AU - Feng, Du

AU - Yin, Xiao-Ming

AU - Li, Min

PY - 2019/5/1

Y1 - 2019/5/1

N2 - Autophagy is a lysosome-mediated degradation pathway that enables the degradation and recycling of cytoplasmic components to sustain metabolic homoeostasis. Recently, autophagy has been reported to have an astonishing number of connections to cancer, as tumor cells require proficient autophagy in response to metabolic and therapeutic stresses to sustain cell proliferation. Autophagy-related gene 4 (ATG4) is essential for autophagy by affecting autophagosome formation through processing full-length microtubule-associated protein 1A/1B-light chain 3 (pro-LC3) and lipidated LC3. An increasing amount of evidence suggests that ATG4B expression is elevated in certain types of cancer, implying that ATG4B is a potential anticancer target. In this review, we address the central roles of ATG4B in the autophagy machinery and in targeted cancer therapy. Specifically, we discuss how pharmacologically inhibiting ATG4B can benefit cancer therapies.

AB - Autophagy is a lysosome-mediated degradation pathway that enables the degradation and recycling of cytoplasmic components to sustain metabolic homoeostasis. Recently, autophagy has been reported to have an astonishing number of connections to cancer, as tumor cells require proficient autophagy in response to metabolic and therapeutic stresses to sustain cell proliferation. Autophagy-related gene 4 (ATG4) is essential for autophagy by affecting autophagosome formation through processing full-length microtubule-associated protein 1A/1B-light chain 3 (pro-LC3) and lipidated LC3. An increasing amount of evidence suggests that ATG4B expression is elevated in certain types of cancer, implying that ATG4B is a potential anticancer target. In this review, we address the central roles of ATG4B in the autophagy machinery and in targeted cancer therapy. Specifically, we discuss how pharmacologically inhibiting ATG4B can benefit cancer therapies.

KW - ATG4

KW - ATG4B

KW - Autophagy

KW - Cancer therapy

UR - http://www.scopus.com/inward/record.url?scp=85066999604&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066999604&partnerID=8YFLogxK

U2 - 10.3390/cancers11050649

DO - 10.3390/cancers11050649

M3 - Article

AN - SCOPUS:85066999604

VL - 11

JO - Cancers

JF - Cancers

SN - 2072-6694

IS - 5

M1 - 649

ER -